SimpleC Wellness Platform With Social Robot Interaction

NCT05296239 | Completed Results

• 1 other identifier: 7645C
• Study Type: interventional
• Target: 26
• Locations: 1 country
• Sites: 2

Brief Summary

This implementation study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.

Conditions

Mood; Quality of Life; Aging; Mild Cognitive Impairment; Cognitive Impairment; Dementia; Engagement, Patient

Keywords

At risk; Diagnosis

Outcome Measures

Primary Outcomes (2)

• Facilitators to Successful Implementation

  \[Interview\] Identified factors that facilitate successful implementation (e.g., WiFi, environmental set up, user perceptions) as derived from analysis of interview. A content analysis of the qualitative data was conducted. This identified themes, such as usefulness or engagement. We report the frequency of each theme mentioned during the interview.

  3 weeks

• Barriers to Successful Implementation

  \[Interview\] Identified factors that are barriers to implementation (e.g., WiFi, environmental set up, user perceptions) as derived from interview. A content analysis of the qualitative data was conducted. This identified themes, such as technology or hard to use. We report the frequency of each theme mentioned during the interview.

  3 weeks

Secondary Outcomes (11)

• Technology Acceptance Model Questionnaire. A 12-item Scale (1-7) With High Scores Indicating Higher Acceptance.

  3 weeks

• Technology Acceptance and Adoption

  3 weeks

• Robotic Social Attributes Scale (RoSAS): Family & Staff

  3 weeks

• Robotic Social Attributes Scale (RoSAS): Residents

  3 weeks

• Robot Social Attributes

  3 weeks

Study Arms (1)

SimpleC Wellness Platform with Social Robot Interaction

EXPERIMENTAL

Three participant groups: Residents, family members, and staff

Other: SimpleC Wellness Platform with Social Robot Interaction

Interventions

SimpleC Wellness Platform with Social Robot Interaction OTHER

Once respondents enroll, they will receive the SimpleC Wellness Platform, including introduction training on the SAR system. During the study period, participants and others will receive instructions for the SAR system and use it as part of scheduled interactions, which includes interactions as part of the general schedule. In the third week, the social robot will be installed, and staff trained in group sessions as available. Participants may use the full SAR system as they are willing. Interactions specific to the virtual and physical robot include notifications to join activities as per community schedule as well as trivia.

SimpleC Wellness Platform with Social Robot Interaction

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• All: Fluent in English
• Resident: 50 years and older
• Resident: lives in Assisted Living Community
• Resident: MMSE score of 13 or higher
• Family member: 18 years and older
• Family member: family or friend of resident
• Family member: no diagnosis of dementia or related disorder
• Staff: 18 years and older
• Staff: works for the Senior Housing Community

You may not qualify if:

• All: pregnant
• Resident: Expecting to move during the study
• Resident: Both legally deaf and blind

Sponsors & Collaborators

• Advanced Medical Electronics: collaborator
• SimpleC, LLC: lead
• University of Georgia: collaborator

Study Sites (2)

University of Georgia

Athens, Georgia, 30602, United States

Location

SimpleC, LLC

Atlanta, Georgia, 30060, United States

Location

MeSH Terms

Conditions

Patient Participation; Cognitive Dysfunction; Dementia; Disease

Condition Hierarchy (Ancestors)

Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior; Cognition Disorders; Neurocognitive Disorders; Mental Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Limitations and Caveats

We experienced SARS-COV-2 related restrictions in availability, flexibility, and access to community, staff, and residents.

Results Point of Contact

• Title: Dr. Anne Adams
• Organization: SimpleC LLC

aadams@simplec.com

770.290.0031

Study Officials

• Anne Adams, PhD

  SimpleC, LLC

  PRINCIPAL INVESTIGATOR

• Jenay Beer, PhD

  jenay.beer@uga.edu

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 23, 2022
• First Posted: March 25, 2022
• Study Start: February 3, 2022
• Primary Completion: March 7, 2022
• Study Completion: March 7, 2022
• Last Updated: March 5, 2026
• Results First Posted: March 5, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (2)